Sintilimab-induced photodistributed bullous pemphigoid: A case report
This case report emphasizes that the clinical manifestations of BP induced by PD-1/programmed death ligand-1 inhibitors can be diverse. Dermatologists need to increase their awareness of BP caused by PD-1/programmed death ligand-1 inhibitors.
Authors
- Xiaowei Shen (ORCID: https://orcid.org/0000-0002-2729-2432)
- Murong Hu
- Wenjuan Cui (ORCID: https://orcid.org/0000-0002-4728-9126)
- Su Wang (ORCID: https://orcid.org/0000-0003-2892-9121)
- Junzhu Xu (ORCID: https://orcid.org/0000-0002-2334-4274)
Institutions
- Zhejiang Chinese Medical University (CN)
- Hainan Maternal and Child Health Hospital (CN)
- The Third Affiliated Hospital of Zhejiang Chinese Medical University (CN)
- Hangzhou Children's Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1097/md.0000000000041448
- Citations
- 2
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.94